LncRNA | MiRNA | Gene | Gene name | Pathway Name | Description | Title | Disease/Tissue | Journal | PubMed ID |
UCA1 | miR-204-5p | BCL2 | BCL2;Bcl-2;PPP1R50 | details
HIF-1 signaling pathway;NF-kappa B signaling pathway;Protein processing in endoplasmic reticulum;Pathways in cancer;Small cell lung cancer;Prostate cancer;PI3K-Akt signaling pathway;Apoptosis;Focal adhesion; Neurotrophin signaling pathway;Cholinergic synapse;Amyotrophic lateral sclerosis (ALS);Colorectal cancer;Hepatitis B;Epstein-Barr virus infection; Toxoplasmosis;Tuberculosis
|
details
The protein levels of CREB1 were significantly up-regulated in CRCs, negatively associated with survival time and positively correlated with the UCA1 expression. The present work provides the first evidence of a UCA1-miR-204-5p-CREB1/BCL2/RAB22A regulatory network in CRC and reveals that UCA1 and CREB1 are potential new oncogenes and prognostic factors for CRC.
|
details
LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-6p
|
Colorectal Cancer | Sci Rep | 27046651 |
H19 | miR-148b | CCK2R | CCKBR;CCK-B;CCK2R;GASR | details
Calcium signaling pathway; Neuroactive ligand-receptor interaction;Gastric acid secretion
|
details
H19 upregulated the miRNA-148b target gene chole- cystokinin-2 receptor (CCK2R) by competitively `sponging' miRNA-148b and then promoted the proliferation and invasiveness of CRC cells.
|
details
Long non-coding RNA H19 promotes colorectal cancer metastasis via negative modulation of miR-148b
|
Colorectal Cancer | Int J Clin Exp Med | Long non-coding RNA H19 promotes colorectal cancer metastasis via negative modulation of miR-148b |
uc002kmd.1 | miR-211-3p | CD44 | CD44;CDW44;CSPG8;ECMR-III;HCELL;HUTCH-I;IN;LHR;MC56;MDU2;MDU3;MIC4;Pgp1 | details
ECM-receptor interaction;Hematopoietic cell lineage;Shigellosis;Epstein-Barr virus infection;Proteoglycans in cancer
|
details
Through a series of experiments, the results showed that lncRNA-uc002kmd.1 regulates CD44 as a molecular decoy for miR211-3p.
|
details
Long Non-Coding RNA ucoo2kmd.1 Regulates CD44-Dependent Cell Growth by Competing for miR-211-3p in Colorectal Cancer
|
Colorectal Cancer | PLoS One | 26974151 |
TUSC7 | miR-211-3p | CDK6 | CDK6;MCPH12;PLSTIRE | details
Hepatitis B;Cell cycle;p53 signaling pathway;PI3K-Akt signaling pathway;Measles;Pathways in cancer; Small cell lung cancer;Non-small cell lung cancer;Viral carcinogenesis;Pancreatic cancer;Glioma;Melanoma;Chronic myeloid leukemia
|
details
TUSC7 overexpression increased the expression level of CDK6, which is a downstream target of miR-211-3p, in both RNA and protein level. Furthermore, luciferase reporter assay indicated that TUSC7 could sponge miR-211-3p.
|
details
The Novel Long Noncoding RNA TUSC7 Inhibits Proliferation by Sponging MiR-211 in Colorectal Cancer
|
Colorectal Cancer | Cell Physiol Biochem | 28214867 |
TUG1 | miR-186 | CPEB2 | CPEB2;CPE-BP2;CPEB-2;hCPEB-2 | details | details
Furthermore, bioinformatics analysis showed that miR-186 could directly bind to TUG1, suggesting TUG1 might worked as a ceRNA to sponge miR-186. Extensively, our study also showed that CPEB2 was the direct target of miR-186 in colorectal cancer cells. Taken together, our study suggests that lncRNA TUG1 mediates MTX resistance in colorectal cancer via miR-186/CPEB2 axis.
|
details
TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis
|
Colorectal Cancer | Biochem Biophys Res Commun | 28302487 |
UCA1 | miR-204-5p | CREB1 | CREB1;CREB | details
Osteoclast differentiation;PI3K-Akt signaling pathway;Antigen processing and presentation; Circadian rhythm;Circadian entrainment;HTLV-I infection;Cholinergic synapse;Dopaminergic synapse;Cocaine addiction;Amphetamine addiction;Tuberculosis;Insulin secretion;Prostate cancer;Huntington's disease;Viral carcinogenesis; Estrogen signaling pathway;Melanogenesis;Hepatitis B;Alcoholism; Vasopressin-regulated water reabsorption
|
details
The protein levels of CREB1 were significantly up-regulated in CRCs, negatively associated with survival time and positively correlated with the UCA1 expression. The present work provides the first evidence of a UCA1-miR-204-5p-CREB1/BCL2/RAB22A regulatory network in CRC and reveals that UCA1 and CREB1 are potential new oncogenes and prognostic factors for CRC.
|
details
LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p
|
Colorectal Cancer | Sci Rep | 27046651 |
CRNDE | miR-136 | E2F1 | E2F1;E2F-1;RBAP1;RBBP3;RBP3 | details
HTLV-I infection;Cell cycle;Hepatitis B;Non-small cell lung cancer;Pathways in cancer;Pancreatic cancer;Glioma;Prostate cancer;Melanoma;Bladder cancer;Chronic myeloid leukemia;Small cell lung cancer
|
details
Further in-depth mechanistic studies revealed that CRNDE functioned as a competing endogenous RNA for miR-136, led to the de-repression of its endogenous target, E2F transcription factor 1 (E2F1).
|
details
Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer
|
Colorectal Cancer | Onco Targets Ther | 28115855 |
MALAT1 | miR-218 | EZH2 | EZH2;ENX-1;ENX1;EZH1;EZH2b;KMT6;KMT6A;WVS;WVS2 | details | details
EZH2 is highly expressed and associated with the 3' end region of lncRNA MALAT1 in colorectal cancer, and this association suppressed the expression of E-cadherin. Furthermore, targeted inhibition of MALAT1 or EZH2 reversed EMT and chemoresistance induced by oxaliplatin. Finally, the interaction between lncRNA MALAT1 and miR-218 was observed, which further indicated its prognostic value in patients who received standard FOLFOX (oxaliplatin combine with 5-fluorouracil and leucovorin) treatment.
|
details
MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2
|
Colorectal Cancer | Mol Cancer Ther | 28069878 |
ROR | miR-145 | p53 | TP53;BCC7;LFS1;P53;TRP53 | details
MAPK signaling pathway;Cell cycle;Epstein-Barr virus infection;p53 signaling pathway;PI3K-Akt signaling pathway;Apoptosis;Thyroid cancer;Melanoma;Basal cell carcinoma;Measles;Chronic myeloid leukemia;Wnt signaling pathway;Neurotrophin signaling pathway;HTLV-I infection;Non-small cell lung cancer;Proteoglycans in cancer;Prostate cancer;Amyotrophic lateral sclerosis (ALS);Transcriptional misregulation in cancer;Pathways in cancer;Pancreatic cancer;Huntington's disease;Hepatitis C;Colorectal cancer;Glioma;Bladder cancer;Endometrial cancer;Hepatitis B;Viral carcinogenesis;Small cell lung cancer;Herpes simplex infection
|
details
Activity of the p53/miR-145 pathway may help explain the role of lincRNA-ROR for stress-induced regulation in CRC therapy.
|
details
The long noncoding RNA-ROR promotes the resistance of radiotherapy for human colorectal cancer cells by targeting the p53/miR-145 pathway
|
Colorectal Cancer | J Gastroenterol Hepatol | 27696511 |
CASC2 | miR-18a | PIAS3 | PIAS3;:ZMIZ5 | details
Ubiquitin mediated proteolysis;Jak-STAT signaling pathway
|
details
Further functional experiments indicate that CASC2 could directly upregulate PIAS3 expression by functioning as a competing endogenous RNA (ceRNA) for miR-18a.
|
details
The long noncoding RNA CASC2 functions as a competing endogenous RNA by sponging miR-18a in colorectal cancer
|
Colorectal Cancer | Sci Rep | 27198161 |
UCA1 | miR-204-5p | RAB22A | details
Endocytosis
|
details
The protein levels of CREB1 were significantly up-regulated in CRCs, negatively associated with survival time and positively correlated with the UCA1 expression. The present work provides the first evidence of a UCA1-miR-204-5p-CREB1/BCL2/RAB22A regulatory network in CRC and reveals that UCA1 and CREB1 are potential new oncogenes and prognostic factors for CRC.
|
details
LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-7p
|
Colorectal Cancer | Sci Rep | 27046651 | |
H19 | miR-138 | ZEB1 | ZEB1;AREB6;BZP;DELTAEF1;FECD6;NIL2A;PPCD3;TCF8;ZFHEP;ZFHX1A | details
Transcriptional misregulation in cancer
|
details
Furthermore, by using bioinformatics study and RNA immunoprecipitation combined with luciferase reporter assays, we demonstrated that H19 functioned as a competing endogenous RNA (ceRNA) for miR-138 and miR-200a, antagonized their functions and led to the de-repression of their endogenous targets Vimentin, ZEB1, and ZEB2, all of which were core marker genes for mesenchymal cells.
|
details
The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer
|
Colorectal Cancer | Oncotarget | 26068968 |
H19 | miR-200a | ZEB1 | ZEB1;AREB6;BZP;DELTAEF1;FECD6;NIL2A;PPCD3;TCF8;ZFHEP;ZFHX1A | details
Transcriptional misregulation in cancer
|
details
Furthermore, by using bioinformatics study and RNA immunoprecipitation combined with luciferase reporter assays, we demonstrated that H19 functioned as a competing endogenous RNA (ceRNA) for miR-138 and miR-200a, antagonized their functions and led to the de-repression of their endogenous targets Vimentin, ZEB1, and ZEB2, all of which were core marker genes for mesenchymal cells.
|
details
The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer
|
Colorectal Cancer | Oncotarget | 26068968 |
H19 | miR-138 | ZEB2 | ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B | details | details
Furthermore, by using bioinformatics study and RNA immunoprecipitation combined with luciferase reporter assays, we demonstrated that H19 functioned as a competing endogenous RNA (ceRNA) for miR-138 and miR-200a, antagonized their functions and led to the de-repression of their endogenous targets Vimentin, ZEB1, and ZEB2, all of which were core marker genes for mesenchymal cells.
|
details
The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer
|
Colorectal Cancer | Oncotarget | 26068968 |
H19 | miR-200a | ZEB2 | ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B | details | details
Furthermore, by using bioinformatics study and RNA immunoprecipitation combined with luciferase reporter assays, we demonstrated that H19 functioned as a competing endogenous RNA (ceRNA) for miR-138 and miR-200a, antagonized their functions and led to the de-repression of their endogenous targets Vimentin, ZEB1, and ZEB2, all of which were core marker genes for mesenchymal cells.
|
details
The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer
|
Colorectal Cancer | Oncotarget | 26068968 |